EMEA-001623-PIP01-14-M04

Key facts

Invented name
Kerendia
Active substance
Finerenone
Therapeutic area
Uro-nephrology
Decision number
P/0298/2021
PIP number
EMEA-001623-PIP01-14-M04
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral (liquid or solid) dosage form
Condition(s) / indication(s)
Treatment of chronic kidney disease
Route(s) of administration
Oral use
Contact for public enquiries
Bayer AG

Tel. +49 30300139003
E-mail: clinical-trials-contact@bayer.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating